SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-22-100817
Filing Date
2022-09-16
Accepted
2022-09-16 16:08:47
Documents
2
Group Members
WENDY GREY

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2226002d2_sc13d.htm SC 13D 63412
2 EXHIBIT 99.1 tm2226002d2_ex99-1.htm EX-99.1 4530
  Complete submission text file 0001104659-22-100817.txt   69708
Mailing Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136 888-963-7881
Organicell Regenerative Medicine, Inc. (Subject) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: SC 13D | Act: 34 | File No.: 005-87575 | Film No.: 221248159
SIC: 3790 Miscellaneous Transportation Equipment

Mailing Address GREYT VENTURES, LLC 20533 BISCAYNE BOULEVARD, SUITE 648 AVENTURA FL 33180
Business Address GREYT VENTURES, LLC 20533 BISCAYNE BOULEVARD, SUITE 648 AVENTURA FL 33180 305-528-6200
Greyt Ventures, LLC (Filed by) CIK: 0001946700 (see all company filings)

IRS No.: 000000000
Type: SC 13D